Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

ABSTRACT:

SUBMITTER: Tauziede-Espariat A 

PROVIDER: S-EPMC11209953 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature